American Diabetes Association - 75th Scientific Sessions (June 5-9, 2015 - Boston, Massachusetts, USA).
The 75th American Diabetes Association (ADA) Scientific Sessions, brought together experts in the diabetes research field to hear hundreds of oral presentations and thousands of poster presentations discussing novel research findings related to diabetes, obesity, fatty liver disease and related medical conditions. A significant number of presentations considered experimental and investigational therapeutic candidates that will potentially aid in the fight against diabetes, which continues to be on the increase worldwide.
Thomson Reuters, Portland, Maryland, USA. scientific.prousjournals@thomsonreuters.com.
M
M
Glessner
D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy*; D055808:Drug Discovery; D000067757:Glucagon-Like Peptide-1 Receptor; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008404:Massachusetts; D018027:Receptors, Glucagon / Q000819:agonists; D016896:Treatment Outcome
D000067757:Glucagon-Like Peptide-1 Receptor; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D018027:Receptors, Glucagon; C000593833:GLP1R protein, human
Diabetes; HM-12525A; HM-14220; LY-2786890; NN-9068; Saxagliptin; Semaglutide; Sitagliptin